NO974580L - Utvalgte opplöselige estere av hydroksylholdige indolkarbazoler - Google Patents

Utvalgte opplöselige estere av hydroksylholdige indolkarbazoler

Info

Publication number
NO974580L
NO974580L NO974580A NO974580A NO974580L NO 974580 L NO974580 L NO 974580L NO 974580 A NO974580 A NO 974580A NO 974580 A NO974580 A NO 974580A NO 974580 L NO974580 L NO 974580L
Authority
NO
Norway
Prior art keywords
hydroxyl
indolcarbazoles
esters
soluble esters
selected soluble
Prior art date
Application number
NO974580A
Other languages
English (en)
Other versions
NO311575B1 (no
NO974580D0 (no
Inventor
John P Mallamo
Robert L Hudkins
Original Assignee
Cephalon Inc
Kyowa Hakko Kogyo Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/417,611 external-priority patent/US5650407A/en
Application filed by Cephalon Inc, Kyowa Hakko Kogyo Kk filed Critical Cephalon Inc
Publication of NO974580D0 publication Critical patent/NO974580D0/no
Publication of NO974580L publication Critical patent/NO974580L/no
Publication of NO311575B1 publication Critical patent/NO311575B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/044—Pyrrole radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H9/00—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical
    • C07H9/06—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical the hetero ring containing nitrogen as ring hetero atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Steroid Compounds (AREA)
  • Cosmetics (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO19974580A 1995-04-05 1997-10-03 Hydroksylholdige indolokarbazoler, farmasöytisk preparat inneholdende slike forbindelser og anvendelse derav NO311575B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/417,611 US5650407A (en) 1995-04-05 1995-04-05 Selected soluble esters of hydroxyl-containing indolocarbazoles
US08/624,707 US5686444A (en) 1995-04-05 1996-03-26 Selected soluble esters of hydroxyl-containing indolocarbazoles
PCT/US1996/004568 WO1996031515A1 (en) 1995-04-05 1996-04-03 Selected soluble esters of hydroxyl-containing indolocarbazoles

Publications (3)

Publication Number Publication Date
NO974580D0 NO974580D0 (no) 1997-10-03
NO974580L true NO974580L (no) 1997-11-27
NO311575B1 NO311575B1 (no) 2001-12-10

Family

ID=27023791

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19974580A NO311575B1 (no) 1995-04-05 1997-10-03 Hydroksylholdige indolokarbazoler, farmasöytisk preparat inneholdende slike forbindelser og anvendelse derav

Country Status (15)

Country Link
US (2) US5686444A (no)
EP (1) EP0827505B1 (no)
JP (1) JPH11504623A (no)
KR (1) KR100429117B1 (no)
AT (1) ATE225793T1 (no)
AU (1) AU700658B2 (no)
BR (1) BR9608044A (no)
CA (1) CA2215111A1 (no)
DE (1) DE69624236T2 (no)
DK (1) DK0827505T3 (no)
ES (1) ES2183941T3 (no)
NO (1) NO311575B1 (no)
NZ (1) NZ306205A (no)
PT (1) PT827505E (no)
WO (1) WO1996031515A1 (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5686444A (en) 1995-04-05 1997-11-11 Cephalon, Inc. Selected soluble esters of hydroxyl-containing indolocarbazoles
AU2012199A (en) * 1997-12-24 1999-07-19 Vertex Pharmaceuticals Incorporated Prodrugs of aspartyl protease inhibitors
US6200968B1 (en) * 1998-08-06 2001-03-13 Cephalon, Inc. Particle-forming compositions containing fused pyrrolocarbazoles
EP1126855B1 (en) * 1998-09-25 2007-05-09 Cephalon, Inc. Use of fused pyrrolocarbazoles for preventing/treating damage to sensory hair cells and cochlear neurons
US7129250B2 (en) 2000-05-19 2006-10-31 Aegera Therapeutics Inc. Neuroprotective and anti-proliferative compounds

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1500989A (fr) * 1966-08-30 1967-11-10 Produits cosmétiques pour les soins de la peau
GB1317185A (en) * 1969-06-20 1973-05-16 Glaxo Lab Ltd Acyloxy-3alpha-hydroxy-pregnones
US4534899A (en) * 1981-07-20 1985-08-13 Lipid Specialties, Inc. Synthetic phospholipid compounds
US4894226A (en) * 1986-11-14 1990-01-16 Cetus Corporation Solubilization of proteins for pharmaceutical compositions using polyproline conjugation
JPH0826036B2 (ja) * 1987-01-22 1996-03-13 協和醗酵工業株式会社 生理活性物質ｋ−２５２の誘導体
US4923986A (en) * 1987-03-09 1990-05-08 Kyowa Hakko Kogyo Co., Ltd. Derivatives of physiologically active substance K-252
JPH07113027B2 (ja) * 1987-12-24 1995-12-06 協和醗酵工業株式会社 Ｋ−２５２誘導体
JPH07505124A (ja) * 1991-11-08 1995-06-08 ザ ユニバーシティ オブ サザン カリフォルニア ニューロトロフィン活性増強のためのｋ−２５２化合物を含む組成物
US5461146A (en) * 1992-07-24 1995-10-24 Cephalon, Inc. Selected protein kinase inhibitors for the treatment of neurological disorders
CA2123895A1 (en) * 1992-09-21 1994-03-31 Tatsuya Tamaoki A therapeutic agent for thrombocytopenia
WO1994020106A1 (fr) * 1993-03-03 1994-09-15 Kyowa Hakko Kogyo Co., Ltd. Renforceur de sensibilite pour agent antineoplasique
AU679752B2 (en) * 1993-05-28 1997-07-10 Cephalon, Inc. Use of indolocarbazole derivatives to treat a pathological condition of the prostate
US5686444A (en) 1995-04-05 1997-11-11 Cephalon, Inc. Selected soluble esters of hydroxyl-containing indolocarbazoles
US5650407A (en) 1995-04-05 1997-07-22 Cephalon, Inc. Selected soluble esters of hydroxyl-containing indolocarbazoles

Also Published As

Publication number Publication date
JPH11504623A (ja) 1999-04-27
EP0827505A1 (en) 1998-03-11
AU700658B2 (en) 1999-01-14
AU5440896A (en) 1996-10-23
DE69624236D1 (de) 2002-11-14
USRE38332E1 (en) 2003-11-25
DE69624236T2 (de) 2003-09-11
DK0827505T3 (da) 2003-02-17
HK1009370A1 (en) 1999-06-04
EP0827505A4 (en) 1998-08-12
KR19980703588A (ko) 1998-11-05
PT827505E (pt) 2003-01-31
WO1996031515A1 (en) 1996-10-10
MX9707632A (es) 1998-06-30
KR100429117B1 (ko) 2004-07-19
BR9608044A (pt) 1999-01-26
EP0827505B1 (en) 2002-10-09
NO311575B1 (no) 2001-12-10
US5686444A (en) 1997-11-11
CA2215111A1 (en) 1996-10-10
ES2183941T3 (es) 2003-04-01
NO974580D0 (no) 1997-10-03
NZ306205A (en) 2000-01-28
ATE225793T1 (de) 2002-10-15

Similar Documents

Publication Publication Date Title
TR199701567T1 (xx) Rapamisin t�revleri.
ATE296304T1 (de) Immunsuppressive wirkstoffe und verfahren
BR9609537A (pt) Composições farmacêuticas
DE69620877D1 (de) Arzneimittelformulierungen für il-12
MX9707431A (es) Inhibidores de la proteina cinasa c.
AU4815197A (en) Tetraphosphonate bicyclic trisanhydrides
DK0758248T3 (da) Formuleringer til faktor IX
PL331091A1 (en) Therapeutic multispecific compounds encompassing antibodies against the fcalpha receptor
AR010062A1 (es) Nuevos benzamidaldehidos y su utilizacion
EP0712384A4 (en) Anhydrous tetrazole gas generant compositions and methods of preparation
DE69326388D1 (de) Verfahren zur Herstellung von Staurosporin-Derivaten
ES2186783T3 (es) Derivados de la dolastatina, su preparacion y uso.
FI896157A0 (fi) Mikrobinen menetelmä syklosporiinien valmistamiseksi
NO305832B1 (no) FremgangsmÕte for fremstilling av metanol
DE69302634D1 (de) Pfropfcopolymer, Verfahren zur Herstellung davon und dieses Copolymer als aktive Komponente enthaltende Weichmacher
DE69619067D1 (de) Verfahren zur Herstellung von 3-Amino-2-oxo-1-Halogenpropan-Derivaten
DE59603916D1 (de) Verfahren zur Herstellung von Imidazo-Benzodiazepin-Derivaten
NO911065L (no) Fremgangsmaate for fremstilling av lipopeptidderivater.
AU2821295A (en) Compositions and methods for the treatment of tumors
MX9305998A (es) 6-heterociclic-4-amino-1, 3, 4, 5,-tetrahidrobenz[cd] indoles yprocedimiento para su preparacion.
NO974580L (no) Utvalgte opplöselige estere av hydroksylholdige indolkarbazoler
FI854910A0 (fi) Anordning foer distortionsfri utstrykning av display under en enskild bild.
DE69707533D1 (de) Verfahren zur Herstellung von 3-Formyl-tetrahydrofuran
DE69708032D1 (de) Verfahren zur Herstellung von Trimethylcatecholdiestern
AU5806098A (en) Methods and devices for ex vivo irradiation of autologous coronary bypass conduit

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees